Tech Company Financing Transactions
Genomind Funding Round
Private investors invested in a $3 million funding round for Genomind. This VC investment round was announced on 7/18/2016.
Transaction Overview
Company Name
Announced On
7/18/2016
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 6 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2200 Renaissance Blvd. 100
King of Prussia, PA 19406
USA
King of Prussia, PA 19406
USA
Phone
Website
Email Address
Overview
Genomind is a personalized medicine company bringing innovation to mental healthcare through genetic testing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Koffler
Chief Financial Officer
Thomas Hess
Chief Information Officer
Jon Levine
Chief Medical Officer
David Krause
Chief Scientific Officer
Jay Lombard
Founder
Ronald Dozoretz
Vice President
David Robbins
Browse more venture capital transactions:
Prev: 7/18/2016: Discors venture capital transaction
Next: 7/18/2016: Civil Maps venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs